What do we really know about the external urethral sphincter?
Continence · 2024-06 · 10 · 101223
DOI: 10.1016/j.cont.2024.101223 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Continence, 2024-06. Verfasst von Karen D McCloskey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Be…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Japan Society for the Promotion of Science, NIHR University College London Hospitals Biomedical Research Centre.
Abstract (Originalsprache)
The external urethral sphincter (EUS), composed of skeletal muscle, along with a smooth muscle-lined internal urethral sphincter (IUS), have crucial roles in maintaining continence during bladder filling and facilitating urine flow during voiding. Disruption of this complex activity has profound consequences on normal lower urinary tract function during the micturition cycle. However, relatively little is known about the normal and pathological functions of these particular muscle types, how activity can be manipulated and regulated and why, for example, loss of EUS function and sarcopenia is associated with ageing. Here we discuss the unique physiological, biochemical and metabolic properties of striated and smooth muscle components of the urethral sphincter, which have distinct roles in maintaining continence during bladder filling. Relevant in vivo models for investigation of pathophysiological mechanisms, and for pre-clinical evaluation of therapeutic approaches are reviewed. Electromyography and Urethral Pressure Profile recordings are pivotal to understanding the function and dysfunction of the EUS and for clinical evaluation of e.g. urinary retention. Pre-clinical and clinical studies have revealed that age- or disease-related tissue remodelling that lead to filling/voiding disorders may be mitigated with emerging therapeutic approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, 97 Lisburn Road, Belfast, Northern Ireland, UK.
- Department of Medicine, Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
- UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
- Department of Cell Physiology, Graduate School of Medical Sciences, Nagoya City University, Nagoya 467-8601, Japan.
- University of Bristol, School of Physiology, Pharmacology and Neuroscience, Faculty of Life Sciences, Bristol BS8 1TD, UK.
Förderung
- NIDDK NIH HHS
- Japan Society for the Promotion of Science
- NIHR University College London Hospitals Biomedical Research Centre
- Medical Research Council
- NIH
Zitieren
APA
McCloskey, K. D., Kanai, A., Panicker, J. N., Hashitani, H., & Fry, C. H. (2024). What do we really know about the external urethral sphincter?. Continence, 10, 101223. https://doi.org/10.1016/j.cont.2024.101223
Vancouver
McCloskey KD, Kanai A, Panicker JN, Hashitani H, Fry CH. What do we really know about the external urethral sphincter?. Continence. 2024;10:101223. doi:10.1016/j.cont.2024.101223
BibTeX
@article{McCloskey2024,
author = {McCloskey, Karen D and Kanai, Anthony and Panicker, Jalesh N and Hashitani, Hikaru and Fry, Christopher H},
title = {What do we really know about the external urethral sphincter?},
journal = {Continence},
year = {2024},
volume = {10},
pages = {101223},
doi = {10.1016/j.cont.2024.101223}
}
EUVIMED